LPAR3 Produkte
(Lysophosphatidic Acid Receptor 3 (LPAR3))
Kategorien
antibodies-online.com steht für hochwertige Forschungsprodukte. Suchen, finden und bestellen Sie Tools mit umfangreichen Validierungsdaten, Bildern, Referenzen. Unser wissenschaftlicher Kundenservice steht Ihnen jederzeit zur Verfügung, wenn Sie Fragen zur Auswahl oder Anwendung unserer Produkte haben.
Ausgewählte LPAR3 Kategorien
LPAR3 Antikörper
High quality antibodies with extensive validation data.
LPAR3 ELISA Kits
Reliable ELISA kits for a wide range of species.
LPAR3 Proteine
Proteins for various applications incl. WB, ELISA, IF etc.
Empfohlene LPAR3 Antikörper
- (4)
- (3)
- (2)
Empfohlene LPAR3 ELISA Kits
- (1)
- (1)
- (1)
Empfohlene LPAR3 Proteine
- (1)
Neueste Publikationen zu unseren LPAR3 Produkten
: "Lysophosphatidic acid directly induces macrophage-derived foam cell formation by blocking the expression of SRBI." in: Biochemical and biophysical research communications, Vol. 491, Issue 3, pp. 587-594, (2017) (PubMed).: "Lysophosphatidic Acid Receptor Antagonism Protects against Diabetic Nephropathy in a Type 2 Diabetic Model." in: Journal of the American Society of Nephrology : JASN, Vol. 28, Issue 11, pp. 3300-3311, (2017) (PubMed).
: "LPA Induces Colon Cancer Cell Proliferation through a Cooperation between the ROCK and STAT-3 Pathways." in: PLoS ONE, Vol. 10, Issue 9, pp. e0139094, (2015) (PubMed).
: "LPA signaling through LPA receptors regulates cellular functions of endothelial cells treated with anticancer drugs." in: Molecular and cellular biochemistry, Vol. 408, Issue 1-2, pp. 147-54, (2015) (PubMed).
: "Different induction of LPA receptors by chemical liver carcinogens regulates cellular functions of liver epithelial WB-F344 cells." in: Molecular carcinogenesis, Vol. 55, Issue 11, pp. 1573-1583, (2015) (PubMed).
: "Expression of lysophosphatidic acid receptors and vascular endothelial growth factor mediating lysophosphatidic acid in the development of human ovarian cancer." in: Cancer letters, Vol. 192, Issue 2, pp. 161-9, (2003) (PubMed).
: "Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate." in: Molecular pharmacology, Vol. 57, Issue 4, pp. 753-9, (2000) (PubMed).
: "Identification of an EDG7 variant, HOFNH30, a G-protein-coupled receptor for lysophosphatidic acid." in: Biochemical and biophysical research communications, Vol. 273, Issue 3, pp. 805-10, (2000) (PubMed).
Synonyme und alternative Namen zu LPAR3
lysophosphatidic acid receptor 3 (LPAR3), lysophosphatidic acid receptor 3 (LOC100038016), lysophosphatidic acid receptor 3 (Lpar3), Edg-7, EDG7, Edg7, GPCR, HOFNH30, LP-A3, LPA3, lpA3, RP4-678I3Bezeichner auf Proteinebene für LPAR3
- endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor, 7
- lysophosphatidic acid receptor 3
- LPA receptor 3
- LPA receptor EDG7
- LPA-3
- calcium-mobilizing lysophosphatidic acid receptor LP-A3
- endothelial cell differentiation gene 7
- lysophosphatidic acid receptor Edg-7
- endothelial differentiation, lysophosphatidic acid G-protein-coupled receptor 7
- putative G protein-coupled receptor snGPCR32
- snGPCR32